Ropinirole extended-release - GlaxoSmithKline
At a glance
- Drug Originator GlaxoSmithKline
- Drug Class Amines; Antiparkinsonians; Indoles; Sleep disorder therapies; Small molecules
- Mechanism of Action Dopamine D2 receptor agonists
- USA Patent Applicants GLAXOSMITHKLINE LLC
- USA Patents 3
- NDAs 1
- Patent Applications 1,703
Table of Contents
Disclaimer